ABBOTT PARK, Ill., June 14, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has approved an infant-specific dose of CREON® (pancrelipase) ...
Creon is a brand-name prescription medication that can treat exocrine pancreatic insufficiency (EPI). The cost of Creon through Medicare may vary depending on many factors, such as a person’s ...
WASHINGTON, May 1 (Reuters) - U.S. health officials have formally approved Solvay SA's enzyme drug Creon for adults and children with a digestive disorder resulting from conditions such as cystic ...
(Recasts first paragraph, adds virus details, Creon revenues) By Susan Heavey WASHINGTON, Nov 28 (Reuters) - U.S. health regulators are concerned about the risk of patients contracting viruses from ...
Nearly all UK pharmacies are experiencing severe “challenges” supplying pancreatic enzyme replacement therapy (PERT), the National Pharmacy Association (NPA) warned. A sample survey by the association ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results